Detalhe da pesquisa
1.
Expression of Surfactant Protein D Distinguishes Severe Pandemic Influenza A(H1N1) from Coronavirus Disease 2019.
J Infect Dis
; 224(1): 21-30, 2021 07 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33668070
2.
Corrigendum: CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome.
Front Immunol
; 12: 700716, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34054884
3.
Clinical and Immunological Factors That Distinguish COVID-19 From Pandemic Influenza A(H1N1).
Front Immunol
; 12: 593595, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33995342
4.
CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome.
Front Immunol
; 12: 633297, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33717172